Riluzole

6 trials 4 recruiting NNeurology/Psychiatry

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

0 Completed trials

6 Sponsors

10 Countries

Phase III

Phase II

Phase I/II

Other

Phase III: 1 Phase II: 2 Phase I/II: 2 Other: 1

Oversight events:

5 corrective measures across 1 trial

View oversight register →

Indications tested

Amyotrophic lateral sclerosis 2

Sponsors using this IMP

Ab Science 1 Asociacion Instituto Biogipuzkoa 1 Centre Hospitalier Regional De Marseille 1 Nura Bio Inc. 1 Oslo University Hospital HF 1 Universita Degli Studi Di Roma La Sapienza 1

All trials

6 total

A Phase 1b/2 Study to Evaluate NB-4746 in Participants with Amyotrophic Lateral Sclerosis. Pending

2025-523939-18-00 Phase I/II 2 countries Nura Bio Inc.
A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N-… Recruiting

2024-519857-13-00 Phase I/II 1 country Asociacion Instituto Biogipuzkoa
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par… Recruiting

2024-513927-18-00 Phase II 1 country Oslo University Hospital HF
RILUSCI Recruiting

2024-514882-20-00 1 country Centre Hospitalier Regional De Marseille
Riluzole in spinocerebellar ataxia type 7 Recruiting

2024-518962-29-00 Phase II 1 country Universita Degli Studi Di Roma La Sapienza
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 Trial to compare the efficacy and safety … Suspended

2024-511244-12-01 Phase III 7 countries Ab Science

Showing 1–6 of 6 trials

← All drugs A–Z